Search research articles
Contact Us
Filters
Showing results (61-70 of 77) with videos related to
Page
of 8
Sort By:
Neuro-Oncology
|
March 25, 2017
VDAC1 is a molecular target in glioblastoma, with its depletion leading to reprogrammed metabolism and reversed oncogenic properties
Tasleem Arif, Yakov Krelin, Itay Nakdimon, et al.
Leukemia & Lymphoma
|
August 20, 2011
Chronic myelogenous leukemia diagnosed in two patients with breast cancer
Sara Abu-Ghanem, Anat Rabinovich, Bertha Delgado, et al.
Journal of Immunotoxicology
|
February 23, 2010
Hodgkin's lymphoma cells exhibit high expression levels of the PICOT protein
Ariel Ohayon, Yael Babichev, Ronit Pasvolsky, et al.
Clinical Orthopaedics and Related Research
|
February 12, 2026
Cigarette Smoking Was Not Associated With Lower Odds of Radiographic Fusion After Combined TLIF and Posterolateral Lumbar (270°) Arthrodesis: A CT-based Retrospective Cohort Evaluation
Nissim Ohana, Daniel Benharroch, Adam Abu-Gameh, et al.
Leukemia & Lymphoma
|
April 11, 2003
Is classical Hodgkin's disease indeed a single entity?
Amalia Levy, Yaron Armon, Jacob Gopas, et al.
Cancer Biology & Therapy
|
August 29, 2009
Nuphar lutea thioalkaloids inhibit the nuclear factor kappaB pathway, potentiate apoptosis and are synergistic with cisplatin and etoposide
Janet Ozer, Nadav Eisner, Elena Ostrozhenkova, et al.
Anticancer Research
|
August 5, 2003
Genomic instability in drug-resistant human melanoma cell lines detected by Alu-I-arbitrary-primed PCR
Gordana Brkic, Jacob Gopas, Nicola Tanic, et al.
Scientific Reports
|
March 30, 2024
A Nuphar lutea plant active ingredient, 6,6'-dihydroxythiobinupharidine, ameliorates kidney damage and inflammation in a mouse model of chronic kidney disease
Daniel Landau, Jannat Khalilia, Eden Arazi, et al.
Molecules (Basel, Switzerland)
|
April 9, 2020
Nuphar lutea Extracts Exhibit Anti-Viral Activity against the Measles Virus
Hila Winer, Janet Ozer, Yonat Shemer, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 25, 2003
IL-1 is required for tumor invasiveness and angiogenesis
Elena Voronov, Dror S Shouval, Yakov Krelin, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 77) with videos related to
Sort By:
Page
of 8
Neuro-Oncology
|
March 25, 2017
VDAC1 is a molecular target in glioblastoma, with its depletion leading to reprogrammed metabolism and reversed oncogenic properties
Tasleem Arif, Yakov Krelin, Itay Nakdimon, et al.
Leukemia & Lymphoma
|
August 20, 2011
Chronic myelogenous leukemia diagnosed in two patients with breast cancer
Sara Abu-Ghanem, Anat Rabinovich, Bertha Delgado, et al.
Journal of Immunotoxicology
|
February 23, 2010
Hodgkin's lymphoma cells exhibit high expression levels of the PICOT protein
Ariel Ohayon, Yael Babichev, Ronit Pasvolsky, et al.
Clinical Orthopaedics and Related Research
|
February 12, 2026
Cigarette Smoking Was Not Associated With Lower Odds of Radiographic Fusion After Combined TLIF and Posterolateral Lumbar (270°) Arthrodesis: A CT-based Retrospective Cohort Evaluation
Nissim Ohana, Daniel Benharroch, Adam Abu-Gameh, et al.
Leukemia & Lymphoma
|
April 11, 2003
Is classical Hodgkin's disease indeed a single entity?
Amalia Levy, Yaron Armon, Jacob Gopas, et al.
Cancer Biology & Therapy
|
August 29, 2009
Nuphar lutea thioalkaloids inhibit the nuclear factor kappaB pathway, potentiate apoptosis and are synergistic with cisplatin and etoposide
Janet Ozer, Nadav Eisner, Elena Ostrozhenkova, et al.
Anticancer Research
|
August 5, 2003
Genomic instability in drug-resistant human melanoma cell lines detected by Alu-I-arbitrary-primed PCR
Gordana Brkic, Jacob Gopas, Nicola Tanic, et al.
Scientific Reports
|
March 30, 2024
A Nuphar lutea plant active ingredient, 6,6'-dihydroxythiobinupharidine, ameliorates kidney damage and inflammation in a mouse model of chronic kidney disease
Daniel Landau, Jannat Khalilia, Eden Arazi, et al.
Molecules (Basel, Switzerland)
|
April 9, 2020
Nuphar lutea Extracts Exhibit Anti-Viral Activity against the Measles Virus
Hila Winer, Janet Ozer, Yonat Shemer, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 25, 2003
IL-1 is required for tumor invasiveness and angiogenesis
Elena Voronov, Dror S Shouval, Yakov Krelin, et al.
Page
of 8